Download - Approach to peripheral neuropathy
![Page 1: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/1.jpg)
Approach to peripheral
neuropathyDr. Parag Moon Senior resident
Dept of neurology GMC Kota
![Page 2: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/2.jpg)
Generalized term including disorders of any cause affecting PNS
May involve sensory nerves, motor nerves, or both
May affect one nerve (mononeuropathy), several nerves together (polyneuropathy) or several nerves not contiguous (Mononeuropathy multiplex)
2
Definitions
![Page 3: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/3.jpg)
Further classified into those that primarily affect the cell body (e.g., neuronopathy or ganglionopathy), myelin (myelinopathy), and the axon (axonopathy)
![Page 4: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/4.jpg)
Most common causes
Disease Diabetes1 2
Paraproteinaemia2 3
Alcohol misuse1
Renal failure1
Vitamin B-12 deficiency1
HIV infection1
Chronic idiopathic axonal neuropathy4
Prevalence 11-41% (depending on
duration, type,and control) 9-10% 7% 4% 3.6%
16% (depending on the population studied, usually much lower)
10-40% of different hospital series
BMJ 2010:341:c6100
BMJ 2010:341:c6100
![Page 5: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/5.jpg)
Loss of function“- symptoms”
Disordered function“+ symptoms”
Sensory “Large Fiber”
↓ Vibration↓ ProprioceptionHyporeflexiaSensory ataxia
Paresthesias
Sensory “Small Fiber”
↓ Pain↓ Temperature
DysesthesiasAllodynia
The clinical response to sensory nerve injury
![Page 6: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/6.jpg)
Loss of function“- symptoms”
Disturbed function“+ symptoms”
Motor nervesLarge fibre
WastingHypotoniaWeaknessHyporeflexiaOrthopedic deformity
Fasciculation Cramps
The clinical response to motor nerve injury
![Page 7: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/7.jpg)
Loss of function“- symptoms”
Disturbed function“+ symptoms”
Autonomic nerves ↓ SweatingHypotensionUrinary retentionImpotenceVascular color changes
↑ Sweating Hypertension
The clinical response to autonomic nerve injury
![Page 8: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/8.jpg)
Mononeuropathy
Focal involvement of a single nerve and implies a local process:
Direct trauma compression or entrapment vascular lesions neoplastic compression or infiltration
![Page 9: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/9.jpg)
Mononeuropathy multiplex
simultaneous /sequential damage to multiple noncontiguous nerves.
Ischemia caused by vasculitis Microangiopathy in diabetes mellitus Less common causes : Granulomatous,
leukemic, or neoplastic infiltration, Hansen's disease (leprosy) and sarcoidosis.
![Page 10: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/10.jpg)
Polyneuropathy Characterized by symmetrical, distal motor
and sensory deficits that have a graded increase in severity distally and by distal attenuation of reflexes,
Rarely predominantly proximal:(E.g: acute intermittent porphyria).
The sensory deficits generally follow a length-dependent stocking-glove pattern
![Page 11: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/11.jpg)
![Page 12: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/12.jpg)
Axonopathies
By far the majority of the toxic, metabolic and endocrine causes
NCVs: CMAPs ↓ 80% lower limit of normal w/o or min velocity or distal motor latency change.
Legs>> arms. EMG: Signs of denervation (acute, chronic) and
reinnervation
![Page 13: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/13.jpg)
Myelinopathies
Unusual by comparison with axonopathies Clues: hypertrophic nerves on exam
global arreflexiaweakness without wastingmotor >> sensory deficitsNCS can discriminate inherited from
acquired
NCS: Distal motor latency prolonged (>125% ULN)Conduction velocities slowed (<80% LLN)May have conduction blockEMG: Reduced recruitment w/o much denervation
![Page 14: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/14.jpg)
![Page 15: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/15.jpg)
![Page 16: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/16.jpg)
![Page 17: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/17.jpg)
Clues for diagnosis
![Page 18: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/18.jpg)
Constitutional symptoms
DM hypothyroidism chronic renal failure liver disease intestinal
malabsorption malignancy connective tissue
diseases
[HIV] drug use Vitamin B6 toxicity alcohol and dietary
habits
•Weight loss, malaise, and anorexia.
![Page 19: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/19.jpg)
Conditions Associated withPainful Peripheral Neuropathy Diabetes and Pre-Diabetes Alcohol neuropathy Chemotherapy
◦ Platinum-based Paraproteinemia Vasculitis and Connective Tissue Diseases Heavy metals and other toxins HIV Amyloidosis Porphyria
![Page 20: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/20.jpg)
Medications Causing Neuropathies Axonal
Vincristine Paclitaxel Nitrous oxide Colchicine Probenecid Isoniazid Hydralazine Metronidazole Pyridoxine Didanosine Lithium Alfa interferon Dapsone
Axonal - continued..Phenytoin Cimetidine Disulfiram Chloroquine Ethambutol Amitriptyline
Demyelinating Amiodarone Chloroquine Suramin Gold
Neuronopathy Thalidomide Cisplatin Pyridoxine
![Page 21: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/21.jpg)
Proximal Symmetric Motor Polyneuropathies
◦ Guillain-Barré syndrome◦ Chronic inflammatory demyelinating
polyradiculoneuropathy ◦ Diabetes mellitus ◦ Porphyria ◦ Osteosclerotic myeloma◦ Waldenstrom's macroglobulinemia ◦ Monoclonal gammopathy of undetermined significance◦ Acute arsenic polyneuropathy ◦ Lymphoma ◦ Diphtheria ◦ HIV/AIDS ◦ Lyme disease◦ Hypothyroidism◦ Vincristine (Oncovin, Vincosar PFS) toxicity
![Page 22: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/22.jpg)
History The temporal course of a neuropathy varies,
based on the etiology.
◦ With trauma or ischemic infarction, the onset will be acute, with the most severe symptoms at onset.
◦ Inflammatory and some metabolic neuropathies have a subacute course extending over days to weeks.
◦ A chronic course over weeks to months is the hallmark of most toxic and metabolic neuropathies.
![Page 23: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/23.jpg)
History A chronic, slowly progressive neuropathy
over many years occurs with most hereditary neuropathies or with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Neuropathies with a relapsing and remitting course include CIDP, acute porphyria, Refsum's disease, hereditary neuropathy with liability to pressure palsies (HNPP), familial brachial plexus neuropathy, and repeated episodes of toxin exposure.
![Page 24: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/24.jpg)
Ischemic neuropathies often have pain as a prominent feature.
Small-fiber neuropathies often present with burning pain, lightning-like or lancinating pain, aching, or uncomfortable paresthesias (dysesthesias).
History
![Page 25: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/25.jpg)
Dying-back (distal symmetric axonal) neuropathies initially involve the tips of the toes and progress proximally in a stocking-glove distribution.
History
![Page 26: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/26.jpg)
Peripheral neuropathy can present as restless leg syndrome.
Proximal involvement may result in difficulty climbing stairs, getting out of a chair, lifting and bulbar involvement can also be seen
History
![Page 27: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/27.jpg)
The clinical assessment should include:◦ careful past medical history, looking for systemic
diseases that can be associated with neuropathy, such as diabetes or hypothyroidism.
History
![Page 28: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/28.jpg)
All patients should be questioned regarding ◦ HIV risk factors◦ diet (nutrition)◦ vitamin use (especially B6) ◦ possibility of a tick bite (Lyme disease) ◦ Constitutional symtoms (malignancy)
History
![Page 29: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/29.jpg)
Differential Diagnosis of Neuropathies
by Clinical Course Acute onset (within days)
Subacute onset (weeks to months)
Chronic course/ insidious onset
Relapsing/ remitting course
Guillain-Barré syndrome
Maintained exposure to toxic agents/medications
Hereditary motor sensory neuropathies
Guillain-Barré syndrome
Acute intermittent porphyria
Persisting nutritional deficiency
Dominantly inherited sensory neuropathy
CIDP
Critical illness polyneuropathy
Abnormal metabolic state
CIDP HIV/AIDS
Diphtheric neuropathy
Paraneoplastic syndrome
Toxic
Thallium toxicity CIDP Porphyria
![Page 30: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/30.jpg)
Physical Examination A cranial nerve examination can provide
evidence of mononeuropathies.
Funduscopic examination may show abnormalities such as optic pallor, which can be present in leukodystrophies and vitamin B12 deficiency.
![Page 31: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/31.jpg)
Thickened nerves
Physical examination
![Page 32: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/32.jpg)
Assessing Autonomic Nervous System
Cardiovagal◦ Heart rate variability
Adrenergic◦ Valsalva maneuver
Induces BP changes and monitors pulse reaction
Postganglionic sudomotor function◦ QSART
![Page 33: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/33.jpg)
Recommendations for lab testing: Screening laboratory tests may be
considered for all patients with DSP (Level C).
Tests with the highest yield of abnormality:1. blood glucose (fasting)2. serum B12 with metabolites (methylmalonic acid, homocysteine)3. SPEP(serum protein electrophoresis)
(Level C).
![Page 34: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/34.jpg)
Other laboratory studies ANA, RF, Anti-dsDNA, Anti-Ro, Anti-La, ANCA
screen, cryoglobulins Urine for heavy metals, porphyrins IFE/urine IFE/ plasma light chain analysis
![Page 35: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/35.jpg)
Neuropathies + Serum Autoantibodies
Antibodies against Gangliosides GM1 : Multifocal motor neuropathy GM1, GD1a : Guillain-Barré syndrome GQ1b : Miller Fisher variant
Antibodies against Glycoproteins Myelin-associated glycoprotein : MGUS
Antibodies against RNA-binding proteins Anti-Hu, antineuronal nuclear antibody 1: Malignant
inflammatory polyganglionopathy
![Page 36: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/36.jpg)
Electrodiagnostic studies
(1) Confirming the presence of neuropathy,
(2) Locating focal nerve lesions,
(3) Nature of the underlying nerve pathology
![Page 37: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/37.jpg)
![Page 38: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/38.jpg)
Distal motor latency prolonged
Nerve conduction velocity slow
Reduced action potential
![Page 39: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/39.jpg)
The limitations of EMG/NCS should be taken into account when interpreting the findings. ◦ There is no reliable means of studying proximal
sensory nerves. ◦ NCS results can be normal in patients with
small-fiber neuropathies◦ Lower extremity sensory responses can be
absent in normal elderly patients.
EMG/NCS are not substitutes for a good clinical examination.
Laboratory Evaluation
![Page 40: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/40.jpg)
Nerve biopsy In vasculitis, amyloid neuropathy, leprosy,
CIDP, Inherited disorders of myelin, and rare axonopathies
The Sural nerve is selected most commonly The superficial peroneal nerve – alternative;
:advantage of allowing simultaneous biopsy of the peroneus brevis muscle through the same incision.
This combined nerve and muscle biopsy procedure increases the yield of identifying suspected vasculitis
![Page 41: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/41.jpg)
Skin biopsy
“For symptomatic patients with suspected polyneuropathy, skin biopsy may be considered to diagnose the presence of a polyneuropathy, particularly SFSN.”
![Page 42: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/42.jpg)
Slow progression◦ Treat causative factors if possible◦ If rapidly progressing
IVIG Immunomodulating agents
Symptom Management
Treatment
![Page 43: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/43.jpg)
Tricyclic antidepressants◦ Amitryptilin, nortryptilin
Calcium channel alpha-2-delta ligands◦ Gabapentin, pregabalin
Calcium channel blocker• Prialt SNRI’s
◦ Duloxetine, venlafaxine Topical Agents
◦ Lidocaine, Capsaicin
Symptom Management
![Page 44: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/44.jpg)
Antiepileptic Drugs◦ Carbamazepine, phenytoin, lacosamide
SSRI’s Opioid analgesics Tramadol Miscellaneous
◦ Botulinum toxin◦ Mexiletine◦ Alpha lipoic acid
NMDA receptors unsuccessful◦ Namenda, Dextromethorphan
Symptom Management
![Page 45: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/45.jpg)
First line drugs • Lidoderm 5% patch• Tricyclic antidepressants• Gabapentin• Pregabalin p.o.• Duloxetine Second line • Carbamazepine• Phenytoin• Venlafaxine • Tramadol
![Page 46: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/46.jpg)
Physical Therapy ◦ Gait and balance training
Assistive devices Safe environment Footwear at all times Foot hygiene
![Page 47: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/47.jpg)
![Page 48: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/48.jpg)
Thanks
![Page 49: Approach to peripheral neuropathy](https://reader035.vdocuments.us/reader035/viewer/2022062303/555ca754d8b42ab2358b4a66/html5/thumbnails/49.jpg)
Clinical Approach to Peripheral Neuropathy: Anatomic Localization and Diagnostic Testing Adina R. Alport et al : Continuum Lifelong Learning Neurol 2012;18(1):13–38.
An Approach to the Evaluation of Peripheral Neuropathies;Mark B. Bromberg; SEMINARS IN NEUROLOGY/VOLUME 30, NUMBER 4 2010
References